His body naturally produces alcohol, he is acquitted after a drunk driving conviction
Who is David Pecker, the first key witness in Donald Trump's trial?
What does the law on the expulsion of migrants to Rwanda adopted by the British Parliament contain?
The shadow of Chinese espionage hangs over Westminster
Colorectal cancer: what to watch out for in those under 50
H5N1 virus: traces detected in pasteurized milk in the United States
What High Blood Pressure Does to Your Body (And Why It Should Be Treated)
Vaccination in France has progressed in 2023, rejoices Public Health France
The right deplores a “dismal agreement” on the end of careers at the SNCF
The United States pushes TikTok towards the exit
Air traffic controllers strike: 75% of flights canceled at Orly on Thursday, 65% at Roissy and Marseille
This is what your pay slip could look like tomorrow according to Bruno Le Maire
Sky Dome 2123, Challengers, Back to Black... Films to watch or avoid this week
The standoff between the organizers of Vieilles Charrues and the elected officials of Carhaix threatens the festival
Strasbourg inaugurates a year of celebrations and debates as World Book Capital
Kendji Girac is “out of the woods” after his gunshot wound to the chest
Skoda Kodiaq 2024: a 'beast' plug-in hybrid SUV
Tesla launches a new Model Y with 600 km of autonomy at a "more accessible price"
The 10 best-selling cars in March 2024 in Spain: sales fall due to Easter
A private jet company buys more than 100 flying cars
This is how housing prices have changed in Spain in the last decade
The home mortgage firm drops 10% in January and interest soars to 3.46%
The jewel of the Rocío de Nagüeles urbanization: a dream villa in Marbella
Rental prices grow by 7.3% in February: where does it go up and where does it go down?
Europeans: “All those who claim that we don’t need Europe are liars”, criticizes Bayrou
With the promise of a “real burst of authority”, Gabriel Attal provokes the ire of the opposition
Europeans: the schedule of debates to follow between now and June 9
Europeans: “In France, there is a left and there is a right,” assures Bellamy
These French cities that will boycott the World Cup in Qatar
NBA: the Wolves escape against the Suns, Indiana unfolds and the Clippers defeated
Real Madrid: what position will Mbappé play? The answer is known
Cycling: Quintana will appear at the Giro
Premier League: “The team has given up”, notes Mauricio Pochettino after Arsenal’s card
the world health Organization (WHO) has stopped a large and global trials with malariamidlet as hydroxychloroquine as a treatment for coronaviruses.
It happens, according to results from a number of other trials have shown no beneficial effect. It writes the news agency Reuters.
The global attempts have been with the participation of several countries.
According to Reuters, the decision to drop the global experiment have been announced at a press conference Wednesday.
at Home, it has also been examined as hydroxychloroquine may help in the fight against coronavirus.
At the beginning of June, the Danish medicines agency on the new coronaforsøg with the agent, who is really developed for use against malaria.
It came to pass, after the Danish medicines agency in late may stopped the Danish trials.
the Reason that the agency chose to douse the Danish trials, there was an article in the british journal The Lancet, which indicated that there were side effects of the medicine.
A part of the results in the article, however, was subsequently withdrawn, as there were doubts about the quality of the test results from the trials with the remedy. There was among other things pointed to an excess mortality.
Because the results in the article were pulled back, felt the Danish medicines agency that it was right to give the green light to try again.
- It is important that we have generated solid knowledge from clinical trials on medication for the Covid-19.
- that is Why it is good that we can once again give the green light for the tests can be resumed, among other things, because there are raised serious doubts about the information in the Lancet study, said the Danish medicines agency director Thomas Senderovitz, in a press release in the beginning of June.
In Denmark has been given the green light to experiment with as hydroxychloroquine against coronavirus for a total of four hospitals.
The case of Gentofte Hospital, copenhagen university hospital, Hvidovre Hospital and Odense university Hospital.
